OptiNose's IPO

OptiNose raised a round of funding on October 13, 2017. Investors include Public.

OptiNose is a specialty pharmaceutical company built around a unique nasal delivery platform. The company is driven by an experienced, world-class team with expertise including drug and device develop…

Articles about OptiNose's IPO: